Annual long term debt:
$2.21B+$469.46M(+27.05%)Summary
- As of today (September 13, 2025), BBIO annual long term debt is $2.21 billion, with the most recent change of +$469.46 million (+27.05%) on December 31, 2024.
- During the last 3 years, BBIO annual long term debt has risen by +$482.69 million (+28.02%).
- BBIO annual long term debt is now at all-time high.
Performance
BBIO Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$2.67B+$317.20M(+13.50%)Summary
- As of today (September 13, 2025), BBIO quarterly long term debt is $2.67 billion, with the most recent change of +$317.20 million (+13.50%) on June 30, 2025.
- Over the past year, BBIO quarterly long term debt has increased by +$942.88 million (+54.67%).
- BBIO quarterly long term debt is now at all-time high.
Performance
BBIO Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
BBIO Long term debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +27.1% | +54.7% |
3 y3 years | +28.0% | +56.2% |
5 y5 years | +2302.4% | +460.8% |
BBIO Long term debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +28.2% | at high | +56.2% |
5 y | 5-year | at high | +2302.4% | at high | +460.8% |
alltime | all time | at high | +3945.7% | at high | +4793.9% |
BBIO Long term debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $2.67B(+13.5%) |
Mar 2025 | - | $2.35B(+6.6%) |
Dec 2024 | $2.21B(+27.0%) | $2.21B(+27.8%) |
Sep 2024 | - | $1.73B(+0.0%) |
Jun 2024 | - | $1.72B(+0.0%) |
Mar 2024 | - | $1.72B(-0.7%) |
Dec 2023 | $1.74B(+0.9%) | $1.74B(+0.3%) |
Sep 2023 | - | $1.73B(+0.1%) |
Jun 2023 | - | $1.73B(+0.3%) |
Mar 2023 | - | $1.73B(+0.3%) |
Dec 2022 | $1.72B(-0.2%) | $1.72B(+0.5%) |
Sep 2022 | - | $1.71B(+0.2%) |
Jun 2022 | - | $1.71B(-0.9%) |
Mar 2022 | - | $1.72B(+0.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $1.72B(+251.1%) | $1.72B(+23.4%) |
Sep 2021 | - | $1.40B(+0.1%) |
Jun 2021 | - | $1.39B(+1.3%) |
Mar 2021 | - | $1.38B(+180.3%) |
Dec 2020 | $490.53M(+434.4%) | $490.53M(+2.2%) |
Sep 2020 | - | $480.13M(+0.9%) |
Jun 2020 | - | $475.68M(+1.2%) |
Mar 2020 | - | $470.02M(+412.1%) |
Dec 2019 | $91.79M(+68.4%) | $91.79M(+22.4%) |
Sep 2019 | - | $75.02M(-86.5%) |
Jun 2019 | - | $554.04M(+3.8%) |
Mar 2019 | - | $533.90M(+879.5%) |
Dec 2018 | $54.51M(-62.1%) | $54.51M |
Dec 2017 | $143.87M | - |
FAQ
- What is BridgeBio Pharma, Inc. annual long term debt?
- What is the all time high annual long term debt for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual long term debt year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly long term debt?
- What is the all time high quarterly long term debt for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly long term debt year-on-year change?
What is BridgeBio Pharma, Inc. annual long term debt?
The current annual long term debt of BBIO is $2.21B
What is the all time high annual long term debt for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual long term debt is $2.21B
What is BridgeBio Pharma, Inc. annual long term debt year-on-year change?
Over the past year, BBIO annual long term debt has changed by +$469.46M (+27.05%)
What is BridgeBio Pharma, Inc. quarterly long term debt?
The current quarterly long term debt of BBIO is $2.67B
What is the all time high quarterly long term debt for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly long term debt is $2.67B
What is BridgeBio Pharma, Inc. quarterly long term debt year-on-year change?
Over the past year, BBIO quarterly long term debt has changed by +$942.88M (+54.67%)